Improving cancer imaging with new PET technology
Dual-tracer multiparametric imaging with a long-axial field-of-view PET to better characterize cancer
['FUNDING_R37'] · UNIVERSITY OF PENNSYLVANIA · NIH-11132094
This study is testing a new type of PET scanner that lets doctors see two different images of tumors in one visit, making it easier and more convenient for cancer patients to get a complete picture of their condition without needing to come back for more tests.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11132094 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing cancer diagnosis by using a novel PET scanner that allows for the simultaneous imaging of two different tracers in a single session. By integrating new radiotracers with traditional glucose metabolism imaging, the study aims to provide a more comprehensive view of tumor biology without requiring patients to return for separate imaging sessions. This approach not only improves the efficiency of the diagnostic process but also aims to reduce patient inconvenience and healthcare resource consumption. Patients will receive both tracers in one visit, streamlining their care.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who require advanced imaging for better characterization of their tumors.
Not a fit: Patients who do not have cancer or those whose conditions do not require advanced imaging techniques may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate cancer diagnoses, improving treatment outcomes for patients.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques, but this specific dual-tracer approach is relatively novel and untested.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PANTEL, AUSTIN — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: PANTEL, AUSTIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Cancers